Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 9Cancer Pain 5Head and Neck Neoplasms 3Colonic Neoplasms 3Agnosia 3Rectal Neoplasms 2Chronic Pain 2Breakthrough Pain 2post laminectomy syndrome 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Terminal Cancer 1Prostatic Neoplasms 1Postoperative Cognitive Complications 1Polyps 1Pleural Effusion, Malignant 1Patient Satisfaction 1Pain, Postoperative 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Ileus 1Failed Back Surgery Syndrome 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Arrhythmias, Cardiac 1

Interventions

Fentanyl 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Failed Back Surgery Syndrome × Fentanyl × Clear all
NCT03523000 2023-01-12

Determining the Prognostic Value of Continuous Intrathecal Infusion

University Hospitals Cleveland Medical Center

Phase 4 Completed
36 enrolled 14 charts

post laminectomy syndrome, Failed Back Surgery Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡